Joost J. Oudejans

Receptor conversion in distant breast cancer metastases

Laurien D.C. Hoefnagel, Marc J. van de Vijver, Henk-Jan van Slooten et al. · Breast Cancer Research · 2010 · 227 citations · Full text

Medicine, Oncology, Endocrine Oncology +13

Rare Occurrence of Classical Hodgkin's Disease as a T Cell Lymphoma

Markus Müschen, Klaus Rajewsky, Andreas Bräuninger et al. · The Journal of Experimental Medicine · 2000 · 211 citations · Full text

Life Sciences, Cell Biology, Pathology +10

Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?

Bellinda A. Bladergroen, Chris J.L.M. Meijer, Rosita L. ten Berge et al. · Blood · 2002 · 154 citations · Full text

Medicine, Immunology, Oncology +17

Molecular subtyping of male breast cancer by immunohistochemistry

Robert Kornegoor, Anoek H J Verschuur‐Maes, Horst Buerger et al. · Modern Pathology · 2011 · 145 citations · Full text

Medicine, Molecular Biology, Oncology +14

Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease

Wieke H.M. Verbeek, Marije S. Goerres, B. Mary E. von Blomberg et al. · Clinical Immunology · 2007 · 140 citations

Life Sciences, Immunology, Oncology +16